文献詳細
特集 直腸癌局所再発に挑む—最新の治療戦略と手術手技
総論
文献概要
【ポイント】
◆直腸癌術後局所再発に対する陽子線治療は2022年4月から保険診療化された.
◆陽子線治療はX線治療と比較して,有害事象を増加させることなく治療効果に優越性がある.
◆腫瘍が消化管・膀胱に隣接している場合,スペーサ手術後の陽子線治療が有効である.
◆直腸癌術後局所再発に対する陽子線治療は2022年4月から保険診療化された.
◆陽子線治療はX線治療と比較して,有害事象を増加させることなく治療効果に優越性がある.
◆腫瘍が消化管・膀胱に隣接している場合,スペーサ手術後の陽子線治療が有効である.
参考文献
1)大腸癌研究会(編);大腸癌治療ガイドライン医師用2022年版.金原出版,2022
2)Tanis PJ, Doeksen A, van Lanschot JJ:Intentionally curative treatment of locally recurrent rectal cancer:a systematic review. Can J Surg 56:135-144, 2013
3)村上昌雄:粒子線治療(陽子線,炭素線).猪俣泰典(編);放射線医学 放射線腫瘍学.金芳堂,2012,pp 24-34
4)厚生労働省保険局医療課 令和4年度診療報酬改定の医療技術.https://www.mhlw.go.jp/content/12400000/000906922.pdf
5)Kim MS, Choi C, Yoo S, et al:Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 38:695-700, 2008
6)Lee JH, Kim DY, Kim SY, et al:Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer. Radiat Oncol 6:51, 2011
7)Tanaka H, Yamaguchi T, Hachiya K, et al:Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment Radiat Oncol J 35:71-77, 2017
8)Watanabe J, Shoji H, Hamaguchi T, et al:Chemoradiotherapy for local recurrence of rectal cancer:a single center study of 18 patients. In Vivo 33:1363-1368, 2019
9)Fok M, Toh S, Easow J, et al:Proton beam therapy in rectal cancer:a systematic review and meta-analysis. Surg Oncol 38:101638, 2021
10)Ogi Y, Yamaguchi T, Kinugasa Y, et al:Effect and safety of proton beam therapy for locally recurrent rectal cancer. J Clin Oncol 36(4_suppl):743-743, 2018
11)Hiroshima Y, Ishikawa H, Murakami M, et al:Proton beam therapy for local recurrence of rectal cancer. Anticancer Res 41:3589-3595, 2021
12)Sauer R, Liersch T, Merkel S, et al:Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO-94 randomized phase Ⅲ trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933, 2012
13)Dagoglu N, Mahadevan A, Nedea E, et al:Stereotactic pelvic reirradiation for locoregional cancer relapse. J Surg Oncol 111:478-482, 2015
14)Chung SY, Koom WS, Keum KC, et al:Treatment outcomes of re-irradiation in locoregionally recurrent rectal cancer and clinical significance of proper patient selection. Front Oncol 9:529, 2019
15)Al-Haidaria G, Skovlundb E, Undsetha C, et al:Re-irradiation for recurrent rectal cancer:a single-center experience. Acta Oncol 59:534-540, 2020
16)Smith T, O'Cathail SM, Silverman S, et al:Stereotactic body radiation therapy reirradiation for locally recurrent rectal cancer:outcomes and toxicity. Adv Radiat Oncol 5:1311-1319, 2020
17)Koroulakis A, Moritoris J, Kaiser A, et al:Reirradiation for rectal cancer using pencil beam scanning proton therapy:a single institutional experience. Adv Radiat Oncol 6:100595, 2021
18)Akasaka H, Sasaki R, Miyawaki D,et al:Preclinical evaluation of bioabsorbable polyglycolic acid spacer for particle therapy Int J Radiat Oncol Biol Phys 90:1177-1185, 2014
掲載誌情報